Literature DB >> 26038397

Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.

Robert W Cross1, Karla A Fenton1, Joan B Geisbert1, Chad E Mire1, Thomas W Geisbert1.   

Abstract

BACKGROUND: Rodent models that accurately reflect human filovirus infection are needed as early screens for medical countermeasures. Prior work in rodents with the Zaire species of Ebola virus (ZEBOV) primarily used inbred mice and guinea pigs to model disease. However, these inbred species do not show some of the important features of primate ZEBOV infection, most notably, coagulation abnormalities.
METHODS: Thirty-six outbred guinea pigs were infected with guinea pig-adapted ZEBOV and examined sequentially over an 8-day period to investigate the pathologic events that lead to death.
RESULTS: Features of disease in ZEBOV-infected outbred guinea pigs were largely consistent with disease in humans and nonhuman primates and included early infection of macrophages and dendritiform cells, apoptosis of bystander lymphocytes, and increases in levels of proinflammatory cytokines. Most importantly, dysregulation of circulating levels of fibrinogen, protein C activity, and antifibrinolytic proteins and deposition of fibrin in tissues demonstrated both biochemical and microscopic evidence of disseminated intravascular coagulation.
CONCLUSIONS: These findings suggest that the outbred guinea pig model recapitulates ZEBOV infection of primates better than inbred rodent models, is useful for dissecting key events in the pathogenesis of ZEBOV, and is useful for evaluating candidate interventions prior to assessment in primates.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ebola; adaptation; animal model; filovirus; guinea pig; pathogenesis; permeability; therapeutics; vaccines; virulence

Mesh:

Substances:

Year:  2015        PMID: 26038397     DOI: 10.1093/infdis/jiv237

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.

Authors:  Anna Z Wec; Zachary A Bornholdt; Shihua He; Andrew S Herbert; Eileen Goodwin; Ariel S Wirchnianski; Bronwyn M Gunn; Zirui Zhang; Wenjun Zhu; Guodong Liu; Dafna M Abelson; Crystal L Moyer; Rohit K Jangra; Rebekah M James; Russell R Bakken; Natasha Bohorova; Ognian Bohorov; Do H Kim; Michael H Pauly; Jesus Velasco; Robert H Bortz; Kevin J Whaley; Tracey Goldstein; Simon J Anthony; Galit Alter; Laura M Walker; John M Dye; Larry Zeitlin; Xiangguo Qiu; Kartik Chandran
Journal:  Cell Host Microbe       Date:  2019-01-09       Impact factor: 21.023

2.  Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.

Authors:  Thomas W Geisbert; James E Strong; Heinz Feldmann
Journal:  J Infect Dis       Date:  2015-06-10       Impact factor: 5.226

Review 3.  Animal Models of Ebolavirus Infection.

Authors:  Marisa C St Claire; Dan R Ragland; Laura Bollinger; Peter B Jahrling
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

Review 4.  Filovirus Strategies to Escape Antiviral Responses.

Authors:  Judith Olejnik; Adam J Hume; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler; Elke Mühlberger
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

5.  A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.

Authors:  Chad E Mire; Joan B Geisbert; Krista M Versteeg; Natalia Mamaeva; Krystle N Agans; Thomas W Geisbert; John H Connor
Journal:  J Infect Dis       Date:  2015-05-09       Impact factor: 5.226

Review 6.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

Review 7.  Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

Authors:  Logan Banadyga; Michael A Dolan; Hideki Ebihara
Journal:  J Mol Biol       Date:  2016-05-14       Impact factor: 5.469

8.  Evaluation of Ebola Virus Countermeasures in Guinea Pigs.

Authors:  Andrea Marzi
Journal:  Methods Mol Biol       Date:  2017

9.  Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.

Authors:  Allen Jankeel; Andrea R Menicucci; Courtney Woolsey; Karla A Fenton; Norma Mendoza; Krista Versteeg; Robert W Cross; Thomas W Geisbert; Ilhem Messaoudi
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

Review 10.  Ebola virus vaccines - reality or fiction?

Authors:  Chad E Mire; Thomas W Geisbert; Heinz Feldmann; Andrea Marzi
Journal:  Expert Rev Vaccines       Date:  2016-05-09       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.